Philipp Schineis

Philipp Schineis

Auto-generated profile, based on publicly available information

Philipp Schineis

Institute of Pharmaceutical Sciences, ETH Zurich 1 , Zurich

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JAJorge Arasa
Jorge Arasa
VCVictor Collado-Diaz
Victor Collado-Diaz
IKIoannis Kritikos
Ioannis Kritikos
JMJessica Danielly Medina-Sanchez
Jessica Danielly Medina-Sanchez
MFMona Carina Friess
Mona Carina Friess
CHCornelia Halin
Cornelia Halin
Dendritic cell (DC) migration to draining lymph nodes (dLNs) is a slow process that is believed to begin with DCs approaching and entering into afferent lymphatic capillaries. From capillaries, DCs slowly crawl into lymphatic collectors, where lymph flow induced by collector contraction supports DC detachment and thereafter rapid, passive transport to dLNs. Performing a transcriptomics analysis of dermal endothelial cells, we found that inflammation induces the degradation of the basement membrane (BM) surrounding lymphatic collectors and preferential up-regulation of the DC trafficking molecule VCAM-1 in collectors. In crawl-in experiments performed in ear skin explants, DCs entered collectors in a CCR7- and β1 integrin–dependent manner. In vivo, loss of β1-integrins in DCs or of VCAM-1 in lymphatic collectors had the greatest impact on DC migration to dLNs at early time points when migration kinetics favor the accumulation of rapidly migrating collector DCs rather than slower capillary DCs. Taken together, our findings identify collector entry as a critical mechanism enabling rapid DC migration to dLNs in inflammation.

27 January 2026 in Journal of Cell Biology
Verified
Journal Article
Open access
VCVictor Collado-Diaz
Victor Collado-Diaz
MCMaria-Nefeli Christakopoulou
Maria-Nefeli Christakopoulou
PSPhilipp Schineis
Philipp Schineis
KBKatharina Blatter
Katharina Blatter
DLDavid Laubender
David Laubender
CHCornelia Halin
Cornelia Halin
Dendritic cell (DC) migration via afferent lymphatics to draining LNs (dLNs) occurs in distinct steps that require the chemokine C–C motif ligand 21 (CCL21). In addition to full-length CCL21, which forms an immobilized perilymphatic gradient, a truncated soluble variant with enhanced gradient-forming capacity (CCL21-ΔC) was recently identified in tissues. We show that in skin, plasmin is continuously activated in a urokinase plasminogen activator (uPA)-dependent manner on lymphatic endothelial cells (LECs) and cleaves full-length CCL21, generating CCL21-ΔC. Inflammatory conditions, while promoting overall DC migration, markedly enhance this process, reducing immobilized perilymphatic CCL21 and increasing dermal CCL21-ΔC levels. Inhibition of uPA-mediated CCL21 cleavage causes full-length CCL21 to accumulate around dermal lymphatics, while CCL21-ΔC levels decline in the skin and dLN subcapsular sinus. Consequently, DC entry into afferent lymphatics is diminished, whereas DC egress from the subcapsular sinus into the LN parenchyma is enhanced. These findings reveal uPA/plasmin-dependent regulation of lymphatic CCL21 gradients and identify CCL21-ΔC as critical for DC migration.